BSECompany Update28 Sept 2026 · 28 Sept 2026, 05:38 pm

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in conitinuation of the Company''s letter dated 13/Aug/2026 regarding stake sale of 51% of the paid up capital of Ishwari Healthcare Private Limited, unlisted subsidiary of the Company, this is to inform you that the Company has completed sale of 209,100 equity shares of Rs.10/- each held by the Company. Consequent to the aforesaid sale, ....

Sudarshan Pharma Industries Ltd · 543828

✦ AI SummaryDivestiture

Sudarshan Pharma Industries Ltd has completed the sale of 51% stake in its unlisted subsidiary Ishwari Healthcare Private Limited to Mr. Amit Lalit Mehta for Rs 1.40 Crores.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

Attachments (1)

📄

48057820-28f9-4f44-92e8-0f298219cf11.pdf

pdf

Download →
View document text
OUDAROHIII PHAR]IA IIIDUEIiliS tTD Head Ofiice : 301 , Aura Biplex, Prem um Rela I Premises. 7 S V Boad, Bor vali lwest). N,4umbai 400092 E-mail : compl ance@sudarshanpharma com Website : www sudarshanpharma.com Board Line : +91-22-42221111 I 43331111 | 42221116 (100 ine) . CIN : L5l496l\i1H2008P1C184997 sP L/CS/SE/2026 2027164 Date: 281h september 2026 The Listing Department BSt Limited BSE Scrlp Code: 543828 Ph iro7.- leejeebhoy lowers, BSE Trading Symbol: SUDARSHAN tla a Street, Mumbai 400001 lSlN: lNE00TV01023 SLrb Discosure pursLrant to Regulation 30 of the SEBl (Listlng Obligations And Disclo\ure Req!irements) ReBUlations, 2015 nt mation of completion of sa e of shares held by the CompanY in lshwari Healthcare Private Llmited l)ear Slr / Madam, PursLrant to ReguLation 30 of SEBl (Llstlng ob igation And Disclosure Requirements) ReguLations, 2015 ('sEBl Listing Reaulations'], ancl n contlnuation of the Company's letter dated 13|'August 2026 regardlfgst.kesaeoi5'l%ofthepald upcaplta oflshwarl Hea thcare Private Limited ("lshwari"), an urllsrcd !!bs diary oI the Company, we w sh to lnfor n you that the Company has completed sale of 2,09,100 equ ty sharcs of Rs.10/ each (51.00% ofthe total paidupcaplta of shwari) heldbythe Company in lshwarl to Mr. Amlt latin Mehta at a consideration of Rs 1.40 Crores. Consequent to the aforesal.l sa e, the shareholding of the Company ln lshwari has been redu'ed from 51.00% to Ni and lshwarl has ceased to be a subsidiary ofthe Company. You are reqLrested to take the same on record Thanks & Rcgards, For, Sudarshan Pharma lndustries [imited /)$atttna Sac in Mehta 6' loint Managing Dire Begd. Otf. : 301, Aura Biplex, Above Kalyan Jewellers, S.V Road, Borivali (West), lvlumbai - 400092.